Correction to: Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Resistance in Bacteria · Urinary Tract Infections Management · Antibiotics Pharmacokinetics and Efficacy
This is a correction to: Sameer Alzaidi, John J Veillette, Stephanie S May, Jared Olson, Katarina Jackson, C Dustin Waters, Allison M Butler, Mary A Hutton, Whitney R Buckel, Brandon J Webb, Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source, Open Forum Infectious Diseases, Volume 11, Issue 2, February 2024, ofad657, https://doi.org/10.1093/ofid/ofad657.
The following clarificatory sentence has been added to the legends of figures 2 and 3: ‘Data represent cumulative incidence curves generated from the propensity-weighted Cox proportional hazards models.’